PDSB Gregory Gene Freitag buys $0 worth of shares
Mar 27, 2025, 10:32 AM
0.00%
What does PDSB do
PDS Biotechnology, based in Princeton, New Jersey, develops clinical-stage immunotherapies for various cancers, including its lead product PDS0101, which targets HPV16. The company went public on October 1, 2015, and has 25 employees.
Gregory Gene Freitag bought 30,120 shares of PDSB on 28 February at $0.00 per share, worth a total of $0. They now own 61,213 PDSB shares, or a 97% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.